X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Immunotherapy

期刊標題檢索 IMMUNOTHERAPY-U 最新評論: Hybrid journals can be selected without being OA. However, for OA, t... (2026-05-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Immunotherapy]您好,您是該頁面的第 28700 位訪客。

期刊簡介
期刊名稱Immunotherapy Immunotherapy
LetPub Score
6.4
50 ratings
Rate

Reputation
7.6

Influence
5.0

Speed
8.5

期刊簡稱IMMUNOTHERAPY-UK
ISSN1750-743X
E-ISSN1750-7448
h-index37
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.200.6660.529
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2206 / 428
Category: Medicine
Subcategory: Immunology and Allergy
Q3132 / 234
Category: Medicine
Subcategory: Immunology
Q3148 / 243

自引率 (2023-2024)3.70%自引率趨勢
掲載範囲
Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.

Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.
官方網站https://www.tandfonline.com/journals/iimy20
在線稿件提交https://rp.tandfonline.com/submission/create?journalCode=IIMY&_gl=1
開放訪問Yes (Hybrid OA journal)
出版商TAYLOR & FRANCIS LTD
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年0
每年文章數104每年文章數趨勢
黃金OA百分比10.00%
Web of Science 四分位
( 2023-2024)
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ3135/183
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1750-743X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【Immunotherapy】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 83.50
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 38.40
    Annual Review of ImmunologyH-index: 279

    CiteScore: 56.50
    ImmunityH-index: 355

    CiteScore: 44.90
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 33.90
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 24.50
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 17.40
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 15.80
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 12.90
    Mucosal ImmunologyH-index: 82

    CiteScore: 13.20
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology523055
    JOURNAL OF IMMUNOLOGY162359
    MOLECULAR IMMUNOLOGY117413
    IMMUNOLOGY114722
    Immunity114261
    Cellular & Molecular Immunology114187
    MEDIATORS OF INFLAMMATION114081
    Vaccine110322
    MICROBIAL PATHOGENESIS110225
    JOURNAL OF EXPERIMENTAL MEDICINE109495
  •  

    Immunotherapy Immunotherapy
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Immunotherapy] 的評論撰寫評論
作者: 田书记


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-05-29 15:52:28 評論於
Hybrid journals can be selected without being OA. However, for OA, the APC is approximately $4740.
(0) 讚! | 田书记

作者: Cc.EL


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-05-28 20:42:16 評論於
Teacher, does this journal require a publication fee?
(0) 讚! | Cc.EL

作者: 加油12138


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2025-11-13 09:37:56 評論於
Not very slow.
(0) 讚! | 加油12138

作者: 张慧雯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-27 09:16:46 評論於
May I ask how long do you usually take for peer review? I submitted my paper and it showed "under consideration + in peer review" after just a few days. It has been almost two months now, is this normal?
(0) 讚! | 张慧雯

作者: 回风念南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 21:42:01 評論於
The peer review process has been taking almost 4 months, quite slow
(0) 讚! | 回风念南

作者: 回风念南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 08:50:24 評論於
It has been over 3 months since submission, and it is still in peer review
(0) 讚! | 回风念南

作者: 矢泽阳朔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-05 21:30:36 評論於
Hello, I just wanted to ask if your article has been submitted for peer review? How long does it usually take in peer review?
(0) 讚! | 矢泽阳朔

作者: 矢泽阳朔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-05 17:56:48 評論於
Hello, may I ask how long your article is in peer review?
(0) 讚! | 矢泽阳朔

作者: 法慧碧菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-21 15:39:09 評論於
I am a half-moon
(0) 讚! | 法慧碧菡

作者: 晨风诗晗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-18 21:20:29 評論於
2个多月
(0) 讚! | 晨风诗晗

作者: 中原含含


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-04 14:49:54 評論於
Hello senior, may I ask how long your article is usually in peer review?
(0) 讚! | 中原含含

作者: 中原含含


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-04 09:25:15 評論於
Hello senior, may I ask how long your article is in peer review?
(0) 讚! | 中原含含

作者: 岭南棠华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-28 19:13:11 評論於
Review speed: 12.0 | Submission hit rate: 50.0 Emphasis on research directions: Immunology; Tumor experience sharing: OK
(0) 讚! | 岭南棠华

作者: 中原含含


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-07 11:10:02 評論於
Could you please tell me how long it usually takes for peer review?
(0) 讚! | 中原含含

作者: 京城博耘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-06 23:45:36 評論於
Submitted on 21st July 2021, a reminder was sent three months after submission, and the feedback from the editor was prompt. Received minor revisions on 22nd November 2021, and three months later, a reminder was sent again. A reminder letter was sent every week, totaling 4 reminders, but the editor did not respond to any of them. One week after sending the final reminder letter, it showed as received on 29th March 2022. The entire submission process lasted for 8 months. Please be cautious when submitting articles if you urgently need them
(0) 讚! | 京城博耘

作者: 京城博耘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-18 15:23:04 評論於
Have you received any response from the editor regarding your reminder letter? It has been 4 months since my first submission and 3 and a half months since minor revision. I have sent three reminder letters already, but the editor has not replied. I am feeling really sad
(0) 讚! | 京城博耘

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:38:11 評論於
The introduction should outline the difficulties you want to address and the questions you want to answer, summarizing existing research and gaps in knowledge
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:40:18 評論於
Introduction is mainly focused on identifying the unresolved issues and the innovative or valuable aspects of one's own research. The Discussion section, on the other hand, involves a detailed comparison and analysis of the strengths and weaknesses of one's research results in relation to previous studies. The emphasis of the two sections is different
(0) 讚! | 维尔娜菲茨杰拉德

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 14:36:24 評論於
Introduction and discussion on how to avoid repetition in writing?
(0) 讚! | 修然小公主

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 15:41:03 評論於
How to write an introduction? How is it different from a discussion?
(0) 讚! | 北国博达

作者: 霹雳清竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-08 20:54:24 評論於
Nice
(0) 讚! | 霹雳清竹

作者: 京城博耘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-01 08:32:37 評論於
Still under review, it's really slow. It has been over 2 months since it's under review, but there is no news at all. How about yours? Any changes now?
(0) 讚! | 京城博耘

作者: 京城博耘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-08 22:55:14 評論於
I was also under consideration at the beginning, and it took a month before I moved to under review. It should be sent for external review now. So your article has not been reviewed yet, this journal is too slow
(0) 讚! | 京城博耘

作者: 璃沙湛雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-24 14:58:58 評論於
It seems to have been under consideration since the submission. Has it already been sent to external review?
(0) 讚! | 璃沙湛雨

作者: 潜龙丝萝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-28 19:42:06 評論於
Having been under review means it is being externally audited, under consideration generally means the external audit result has come back and is now in the hands of the editor. There should be a result soon
(0) 讚! | 潜龙丝萝

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Immunotherapy] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*